Emanuela Fantinel
Verona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33-REGAL study.
Journal: Therapeutic advances in medical oncology
Published: January 26, 2026
Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study.
Journal: Cancer immunology, immunotherapy : CII
Published: October 24, 2025
Role of large language models in the multidisciplinary decision-making process for patients with renal cell carcinoma: a pilot experience.
Journal: NPJ precision oncology
Published: March 20, 2025
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study.
Journal: European urology
Published: December 04, 2023
PARP Inhibitors in Metastatic Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis of Existing Evidence.
Journal: Clinical genitourinary cancer
Published: September 15, 2023
Remarkable response to gemcitabine rechallenge in advanced urothelial carcinoma: a case report.
Journal: Anti-cancer drugs
Published: October 07, 2022
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
Journal: Journal of translational medicine
Published: July 11, 2022
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study.
Journal: European urology
Published: June 01, 2021
Exceptional response to immunotherapy in association with radiotherapy in patient with breast metastasis from urothelial carcinoma: A case report.
Journal: Urology case reports
Published: September 27, 2020
PD-L1 Expression in De Novo Metastatic Castration-sensitive Prostate Cancer.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: July 02, 2019
Last Updated: 09/26/2026